FrankyDeMeyer
Multinationals with significant operational footprints in Ireland, Germany, and Switzerland could bear the brunt of the Trump administration’s plans to impose tariffs on the pharmaceutical, life science, and medical device industry, global consultancy firm PwC said in a recent report.
